FIELD: medicine.
SUBSTANCE: method for the treatment of a human subject suffering from hematopoietic malignant tumor and method for the prediction of RARA agonist efficiency in a human subject suffering from hematopoietic malignant tumor are proposed, where the method includes a stage of determination of a hematopoietic malignant cell from a subject.
EFFECT: proposed group of inventions provides for the effective treatment of a patient suffering from cancer.
44 cl, 33 dwg, 3 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RARA AGONISTS FOR THE TREATMENT OF AML AND MDS | 2017 |
|
RU2799789C2 |
| METHOD FOR DIAGNOSING ACUTE LEUKEMIA AND KITS FOR ITS IMPLEMENTATION | 2021 |
|
RU2806591C2 |
| BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH VEGF ANTAGONISTS | 2013 |
|
RU2659173C2 |
| BIOMARKERS AND APPLICATIONS IN TREATING VIRAL INFECTIONS, INFLAMMATIONS OR CANCER | 2019 |
|
RU2820481C2 |
| B-CELLS FOR IN VIVO THERAPEUTIC DELIVERY AND THEIR DOSES | 2018 |
|
RU2812477C2 |
| PHOSPHODIESTERASE 4D7 AS PROSTATE CANCER MARKER | 2010 |
|
RU2651474C2 |
| METHODS FOR PREDICTING PROSTATE CANCER | 2016 |
|
RU2760577C2 |
| IMMUNOMAGNETIC SEPARATION OF CELLS USED FOR IDENTIFICATION OF GENES ASSOCIATED WITH SITE-PREFERABLE CANCER METASTASIS FORMATION | 1997 |
|
RU2180963C2 |
| TOM34 GENE RELATED TO COLON CANCER | 2006 |
|
RU2526196C2 |
| GENE TOM34 ASSOCIATED WITH CANCER OF LARGE INTESTINE | 2006 |
|
RU2449020C2 |
